
Research consistently shows that while Vitamin K is crucial for normal blood coagulation, Vitamin K2 does not lead to excessive clotting or increased blood thickness. Today, we are addressing the widespread myth that Vitamin K2 can cause elevated coagulation levels.
Vitamin K is vital for maintaining proper blood coagulation, a natural and healthy process that prevents excessive bleeding. This raises a common question: Does Vitamin K increase blood thickness or elevate the risk of thrombosis?
Do you know Vitamin K?
Vitamin K, historically viewed as a single nutrient, is a group of fat-soluble vitamins essential for human health. The two key forms are Vitamin K1, primarily found in leafy greens, and Vitamin K2, present in small amounts in fermented foods.
Vitamin K1 plays a primary role in supporting blood clotting by activating clotting factors in the liver. In contrast, Vitamin K2 has additional health benefits, including supporting bone strength and cardiovascular health. Unlike K1, Vitamin K2 stays in the bloodstream longer, making it more bioavailable for various tissues.
Vitamin K2 and Blood Coagulation
Prothrombin, a protein activated by Vitamin K, is central to the blood coagulation process. It influences clotting when necessary but does not determine blood thickness. Vitamin K ensures that clotting factors function optimally, preventing harmful bleeding. A deficiency in Vitamin K, however, leads to impaired coagulation, resulting in prolonged bleeding.
While Vitamin K2 activates clotting proteins like K1, it does not increase the risk of thrombosis in healthy individuals. The liver primarily uses Vitamin K1 for coagulation processes, leaving K2 available for other functions, such as maintaining cardiovascular health.
Coumarin: The Only Concern with Vitamin K2
Patients on vitamin K antagonists like warfarin should consult a healthcare provider before supplementing with Vitamin K2. Warfarin and similar drugs inhibit Vitamin K, which can affect bone and cardiovascular health over time. Fortunately, new anticoagulant drugs, such as direct oral anticoagulants (DOACs) and anti-platelet medications like aspirin, do not interfere with Vitamin K2, allowing for safe supplementation.
MenaQ7®: Proven Safe and Effective
Clinical research on MenaQ7® Vitamin K2 has demonstrated no increase in blood clotting risk or coagulation levels. Studies across children, adults, and patients with kidney issues confirm stable thrombin and coagulation parameters, reinforcing the safety and efficacy of Vitamin K2 for supporting bone and cardiovascular health.
With advancements in antithrombotic medications, patients can safely integrate MenaQ7® Vitamin K2 into their routines to promote healthy aging and development while maintaining robust cardiovascular and bone health.
Do you want to know more? Please, do not hesitate to contact our experts.
Ingredients mentioned

MenaQ7®
Active ingredients
Vitamin K2: MenaQ7® is the optimal bioavailable 99.8% all-trans vitamin K2 as MK-7, produced in the only European plant manufacturing K2 by natural fermentation under the highest quality standards and sustainability measures.
Mobility & Joint
Wellness & Immune
Reproduction & Women’s
Bone
Cardiovascular
Menopause

MenaQ7® Palm-Free MCT Oil
Active ingredients
Vitamin K2 : for oil-based, sustainable, and palm-free finished product formulations, MenaQ7® Palm-Free MCT Oil combines natural fermentation's purest all-trans vitamin K2, the clinically proven health benefits of MenaQ7®, and a 100% organic coconut oil carrier. Produced in Europe in Gnosis GMP certified plant.
Mobility & Joint
Wellness & Immune
Reproduction & Women’s
Bone
Cardiovascular
Menopause

MenaQ7® Matrix
Active ingredients
Vitamin K2 : The clinically proven health benefits of MenaQ7® delivered via an award-winning Vitamin K2 Matrix protective technology. Formulate even under the harshest conditions of supplement & food processing with MenaQ7® Matrix, the natural choice for stable and protected Vitamin K2, without coating, nor additives.
Mobility & Joint
Wellness & Immune
Reproduction & Women’s
Bone
Cardiovascular
Menopause
Latest news & videos

- MenaQ7®
- Mobility & Joint
- News
- Apr 29, 2025
FSANZ Approves Vitamin K2 for Food for Special Medical Purposes
The Food Standards Australia New Zealand (FSANZ) has officially approved the use of Vitamin...

- Lynside® Nutritional Yeasts
- News
- Wellness & Immune
- Apr 23, 2025
Lynside® Forte Se+ for Skin Protection Against Sun Exposure
Selenium yeast boosts skin defenses against sun damage by fighting oxidative stress, supporting repair,...

- MenaQ7®
- Mobility & Joint
- MyCondro®
- Apr 17, 2025
Successful Vital Nutrients Symposium:
Shaping the Future of Healthy Aging
The Vital Nutrients Symposium 2025, held in Kassel, Germany, offered an excellent platform to...